Photodynamic therapy with verteporfin for choroidal neovascularization in patients with angioid streaks
- 1 September 2002
- journal article
- clinical trial
- Published by Elsevier in American Journal of Ophthalmology
- Vol. 134 (3) , 360-366
- https://doi.org/10.1016/s0002-9394(02)01626-4
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Photodynamic therapy of subfoveal choroidal neovascularization in pathologic myopia with verteporfinOphthalmology, 2001
- Verteporfin therapy of subfoveal choroidal neovascularization in age-related macular degeneration: two-year results of a randomized clinical trial including lesions with occult with no classic choroidal neovascularization—verteporfin in photodynamic therapy report 2American Journal of Ophthalmology, 2001
- Treatment of subfoveal choroidal neovascularisation in age related macular degeneration: focus on clinical application of verteporfin photodynamic therapyBritish Journal of Ophthalmology, 2001
- Intravenous Infusion of Liposomal Benzoporphyrin Derivative for Photodynamic Therapy of Experimental Choroidal NeovascularizationArchives of Ophthalmology (1950), 1996
- Photodynamic Therapy of Experimental Choroidal Neovascularization Using Lipoprotein-Delivered BenzoporphyrinArchives of Ophthalmology (1950), 1995
- Vascular Targeting in Photodynamic Occlusion of Subretinal VesselsOphthalmology, 1994
- Visual Impairment and Disability in Older AdultsOptometry and Vision Science, 1994
- Photodynamic Therapy of Experimental Choroidal Melanoma Using Lipoprotein-delivered BenzoporphyrinOphthalmology, 1994
- Biodistribution of tritiated benzoporphyrin derivative (3H-BPD-MA), a new potent photosensitizer, in normal and tumor-bearing miceJournal of Photochemistry and Photobiology B: Biology, 1990
- Angioid streaksSurvey of Ophthalmology, 1982